Rated 5 out of 5 Janice S
In December 2020, the US Food and Drug Administration (FDA) approved labeling changes stating that Januvia (sitagliptin), Janumet (sitagliptin and metformin hydrochloride), and Janumet XR (sitagliptin and metformin hydrochloride extended-release) are not proven to improve glycemic (blood sugar) control in children aged 10 to 17 with type 2 diabetes
This is a lot more than the weight loss seen in others who took a placebo
doi: 10.1253/circj.70.1052 245
Regular screening, prompt symptom recognition, and adherence to monitoring protocols constitute essential components of safe tirzepatide therapy, enabling patients to access the medications metabolic benefits while protecting their visual health
Disadvantages: Cannot penetrate deeply into the skin Cannot create systemic effects like the capsule and tablet forms Works slowly and takes time to produce effects Topical Glutathione is often consumed alongside oral and skincare products